Project Affinity: Excess Cancer Blood Testing
NCT04724005 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 613
Last updated 2022-09-29
Summary
Study investigating cancer blood samples on an iterative measurement systme
Conditions
Interventions
- OTHER
-
No drug
No drug used
Sponsors & Collaborators
-
Entia Ltd
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-15
- Primary Completion
- 2022-08-31
- Completion
- 2022-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Afatinib With CT and RT for EGFR-Mutant NSCLC
NCT01553942 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Tumor Microenvironment Surveillance on Simultaneous Liver Metastases Extensive Stage Small Cell Lung Cancer
NCT05055999 ·Status: COMPLETED
-
Afatinib and Cetuximab in Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Positive Non-small-cell Lung Cancer
NCT03727724 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate Safety, Tolerability, Pharmacokinetics and Anti-tumor Activity of AZD3759
NCT03360929 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
NCT02488694 ·Status: TERMINATED ·Phase: PHASE2
-
Monitoring Alectinib Treatment by Detection of ALK Translocations in Serial Blood Samples From Non-Small Cell Lung Cancer Patients
NCT04708639 ·Status: UNKNOWN
-
Tumour Characterisation to Guide Experimental Targeted Therapy - National
NCT04723316 ·Status: RECRUITING
-
Efficiency of Icotinib in Plasma ctDNA EGFR Mutation-positive Patients Diagnosed With Lung Cancer
NCT03346811 ·Status: UNKNOWN ·Phase: PHASE2
-
Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA
NCT02629523 ·Status: COMPLETED ·Phase: PHASE2
-
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
NCT03711422 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of [14C]GB491 in Male Healthy Subjects
NCT05860582 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC)
NCT02299505 ·Status: COMPLETED ·Phase: PHASE1
-
The Absorption, Metabolism and Excretion of [14C]Ensartinib in Human
NCT03804541 ·Status: UNKNOWN ·Phase: PHASE1
-
Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
NCT02191891 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium
NCT03761901 ·Status: COMPLETED
-
Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)
NCT03416231 ·Status: UNKNOWN ·Phase: PHASE2
-
Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older
NCT02514174 ·Status: COMPLETED ·Phase: PHASE4
-
Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC)
NCT00568841 ·Status: UNKNOWN ·Phase: PHASE2
-
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
NCT04056247 ·Status: ACTIVE_NOT_RECRUITING
-
EXPRESS: EXcePtional RESponSe - Exceptional and Unexpected Response to Targeted Therapies
NCT02701907 ·Status: COMPLETED ·Phase: NA
-
Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
NCT01931306 ·Status: APPROVED_FOR_MARKETING
-
An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types
NCT01472003 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Utilization of Newly Approved Oncology Medications
NCT02783885 ·Status: UNKNOWN
-
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
NCT05146219 ·Status: COMPLETED ·Phase: PHASE2
-
Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S.
NCT04750824 ·Status: COMPLETED